ID
45470
Description
Principal Investigator: Jay Shendure, PhD, University of Washington, Seattle, WA, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000500 The overall purpose of this study was to demonstrate the feasibility of producing haplotype-phased whole genome sequence data from a fetus using free fetal DNA isolated from maternal plasma collected during the first half of gestation.
Lien
Mots-clés
Versions (2)
- 02/11/2022 02/11/2022 - Tabea Kampen
- 13/12/2022 13/12/2022 - Kristina Keller
Détendeur de droits
Jay Shendure, PhD, University of Washington, Seattle, WA, USA
Téléchargé le
13 décembre 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000500 Non-Invasive Whole Genome Sequencing of a Human Fetus
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject ID aliases, and affection status.
- The pedigree data table contains pedigree and gender information of study participants. There are 2 family trios.
- The subject sample data table contains mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes a mapping of sample IDs to other sample ID aliases and sample use.
- The sample attributes data table includes body site where sample was extracted, sample analyte type and tumor status.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject ID aliases, and affection status.
- The pedigree data table contains pedigree and gender information of study participants. There are 2 family trios.
- The subject sample data table contains mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes a mapping of sample IDs to other sample ID aliases and sample use.
- The sample attributes data table includes body site where sample was extracted, sample analyte type and tumor status.
C1320396 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
C0086582 (UMLS CUI [1,4])
C0444245 (UMLS CUI [2,1])
C0015671 (UMLS CUI [2,2])
C0026591 (UMLS CUI [2,3])
C0008059 (UMLS CUI [3,1])
C0443281 (UMLS CUI [3,2])
C0444245 (UMLS CUI [3,3])